The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial

Abstract Background This study aimed to investigate the medroxyprogesterone acetate (MPA) + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who received in vitro fertilization (IVF). Methods Three hundred patients wit...

Full description

Bibliographic Details
Main Authors: Haiyan Guo, Tong Du, Hongyuan Gao, Qianwen Xi, Ling Wu, Qifeng Lyu, Qianqian Zhu
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Reproductive Health
Subjects:
Online Access:https://doi.org/10.1186/s12978-022-01500-z